Dr. Philip Allingham, PhD, DGPT

Dr. Philip Allingham, a senior toxicology and preclinical development leader, joined WuXi AppTec Testing in 2025 and brings over 20 years of experience directing in vivo safety studies across pharmaceutical, chemical, and medical device programs for European and US regulatory submissions. His expertise spans dose-escalation and biodistribution studies, disease models, and GLP toxicology for modalities including small molecules, biologics, ADCs, mRNA, and AAV therapies. His previous leadership experience includes Head of Toxicology, Head of Test Facility, and Chief Operations and Compliance Officer positions in Germany and Spain. Dr. Allingham holds a PhD in Biology from Ludwig-Maximilians-University Munich and an Expert in Toxicology, DGPT certification from the German Society of Experimental and Clinical Pharmacology and Toxicology. Dr. Allingham also contributes to advancing translational toxicology and regulatory science as a published author and conference contributor.